Coronavirus Vaccine: "It's a trial on humans and not animals", doctors slam ICMR's August 15 deadline for launching Covaxin
WASHINGTON: Global coronavirus cases exceeded 11 million on Friday, according to a Reuters tally, marking another milestone in the spread of the disease that has killed more than half a million people in seven months. The number of cases is more than double the figure for severe influenza illnesses recorded annually, according to the World Health Organization. Many hard-hit countries are easing lockdowns put in place to slow the spread of the coronavirus while making extensive alterations to work and social life that could last for a year or more until a vaccine is available. Some countries are experiencing a resurgence in infections, leading authorities to partially reinstate lockdowns, in what experts say could be a recurring pattern into 2021.
NEW DELHI: Aiming to launch an indigenous Covid-19 vaccine by August 15, the Indian Council of Medical Research has written to select medical institutions and hospitals to fast-track clinical trial approvals for the vaccine candidate Covaxin being developed in collaboration with Bharat Biotech. Twelve clinical trial sites have been identified at present and the apex health research body has asked the medical institutions and principal investigators to ensure that the subject enrolment is initiated no later than July 7. The Covid-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the nod for human clinical trials from the DCGI. Noting that this was the first
WASHINGTON: The US is "going in the wrong direction" with the coronavirus surging badly enough that Dr Anthony Fauci told senators Tuesday some regions are putting the entire country at risk — just as schools and colleges are wrestling with how to safely reopen. With about 40,000 new cases being reported a day, Fauci, the government's top infectious disease expert, said he "would not be surprised if we go up to 100,000 a day if this does not turn around." "I am very concerned," he told a hearing of the Senate Health, Education, Labor and Pensions committee. Infections are rising rapidly mostly in parts of the West and South, and Fauci and other public health experts said Americans everywhere will
NEW DELHI: Prime Minister Narendra Modi on Tuesday chaired a high-level meeting to review the preparations being undertaken for vaccination against Covid-19, as and when a vaccine is available. The Prime Minister directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately. The current status of Indian and global vaccine development efforts was also reviewed at the meeting. The Prime Minister highlighted that India's responsibility and commitment to the global community to play an enabling role in global vaccination efforts against Covid-19. PM-CARES (Prime Minister's Citizen Assistance and Relief in Emergency Situations) Fund Trust had earlier allocated
KOLKATA: Johnson & Johnson is preparing the ground for the entry of a vaccine against Covid-19 and is expanding its manufacturing capacity to supply more than one billion doses through 2021 in a not-for-profit project aimed at the common person, says its top scientist. The US-based pharma giant, which has already advanced its schedule of starting human trials of its candidate vaccine to the second half of July from September, is working on the twin fronts of expanding existing manufacturing capacity and establishing new units, Chief Scientific Officer Paul Stoffels told PTI. "We plan to begin production at risk and are committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use. We are
HYDERABAD: Vaccine maker Bharat Biotech on Monday said it has successfully developed India’s first vaccine candidate for Covid-19 in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). Called Covaxin, the indigenous, inactivated vaccine has also got approval from the Indian drugs regulator, Drug Controller General of India (DCGI), for conducting phase I and II human clinical trials that will begin across the country in July 2020, Bharat Biotech said. The SARS-CoV-2 virus strain was isolated from an asymptomatic Covid-19 patient at NIV, Pune, and transferred to Bharat Biotech, which grew and replicated the virus and developed the vaccine candidate at its BSL-3 (Bio Safety Level-3) high containment facility manufacturing facility at Genome Valley
BEIJING: China's military has approved a coronavirus vaccine for use within its ranks that has been developed by its research unit and a biotech firm, the company said Monday. Organisations around the world are racing to find ways to treat and prevent the deadly pathogen, which first emerged in the central Chinese city of Wuhan and has since killed over half a million people worldwide. More than half of 17 candidate vaccines identified by the World Health Organization (WHO) that are in clinical evaluation involve Chinese companies or institutes. Hong Kong-listed CanSino Biologics said in a filing to the stock exchange that data from clinical trials showed the Chinese military vaccine had a "good safety profile" and potential to prevent
WASHINGTON: Two in five Indian-Americans are worried about their long-term financial stability due to the Covid-19 pandemic, but almost all are changing their lifestyle, according to a first-of-its-kind survey about the contagion's impact on the community. Similarly, 30 per cent of the Indian-Americans have had financial impact on their job and internship, the Foundation for India and Indian Diaspora Studies (FIIDS) said in a report on Saturday. According to the report which is based on a recent Covid-19 survey, one in six tested positive or know a family member of the Indian community member who tested positive. However, only a few Indian-Americans faced immigration impacts from this pandemic. “FIIDS conducted the survey of Indo-Americans to find out the impact of
GENEVA: Experts behind a global push to develop and roll out a vaccine and other treatment for the coronavirus say their ambitions require a big budget. The World Health Organization and its allies made a pitch for their ACT-Accelerator that aims to get a Covid-19 vaccine and treatment tools to the neediest people around the world, no matter the cost. They were speaking a day before a European Union conference to drum up support and funds for the initiative that the United States has shunned so far. Ultimately, WHO and partners say the project needs more than $31 billion through the end of 2021, for vaccines, therapeutics and diagnostics to fight a disease that has caused more than 9.6 million
NEW DELHI: Amid the surge in Covid-19 cases in the country, Union minister Nitin Gadkari on Sunday expressed confidence that there will be a vaccine for the deadly disease very soon. Addressing a 'Gujarat Jan Samvad' rally via video conference Gadkari said that the corona crisis will not last long and scientists will develop a vaccine soon. "The corona crisis will not last long. Our scientists and scientists in other countries are working day and night to develop the vaccine. I am confident that we will get the vaccine very soon," Gadkari said. According to the Union Ministry of Health and Family Welfare, India witnessed its highest-ever spike of 11,929 new cases in the last 24 hours, the total
Indian Council of Medical Research (ICMR) has collaborated with Bharat Biotech International Limited (BBIL) for the development of a vaccine wherein an isolated spike protein of the novel coronavirus has been identified and researched. The vaccine's workability has been found to strengthen the body's immunity and spike up production of antibodies, which could defend the body against such viral agents.Apart from this, Bharat Biotech, which is a renowned vaccine maker has already started the testing phase of another vaccine against coronavirus, CoroFlu, making use of an influenza flu strain, which has been developed in collaboration with international virologists.
NEW DELHI: As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year. The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of Covid-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country. PM CARES Fund Trust has decided to allocate Rs 100 crore for support to coronavirus vaccine development efforts. Referring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and industry have come together in cutting-edge vaccine design
NEW DELHI: The resumption of competitive hockey in various countries amid the COVID-19 pandemic will depend entirely on local conditions, the International Hockey Federation (FIH) has said. The FIH said that any return to training and competitive hockey has to be "carefully implemented to prevent any resurgence in infection". According to a top FIH official said while a vaccine is needed to "return to normal competition", restarting the sport at different levels is dependent on conditions in various member nations. "We have never said that hockey can only start once the COVID-19 vaccine is developed...this document (the five-stage resumption plan) has been prepared only to give them a framework on how to start things under precaution," an FIH official told PTI. "In the end
कैनबरा: चीन की लैब पर मौत वाला वायरस बनाने का आरोप है तो कुछ लैब ऐसी भी हैं जो लोगों को जिंदगी देने के लिए रिसर्च कर रही हैं. मौजूदा समय में लगभग हर देश कोरोना वायरस (Coronavirus) के कहर का सामना कर रहा है. ऐसे में दुनियाभर के वैज्ञानिकों और शोधकर्ताओं से यही उम्मीद की जा रही है कि वो जल्द से जल्द कोरोना वायरस की वैक्सीन तैयार करें. जिससे लोगों को इस जानलेवा बीमारी के खतरे से बचाया जा सके. इस बीच कोरोना वैक्सीन को लेकर ऑस्ट्रेलिया से एक अच्छी खबर आई है. कोरोना वायरस के खतरे से जूझ रही पूरी दुनिया को उस वैक्सीन का बेसब्री से इंतजार है जो लोगों को कोरोना वायरस से बचा सके. जिसके
Washington, US President Donald Trump while addressing the daily White House coronavirus briefing said "we are very close to a vaccine", after noting vaccine trials taking place in the US, Germany, the United Kingdom and China. He was joined by Vice-President Mike Pence and Deborah Birx, the White House coronavirus taskforce co-ordinator, the BBC reported. "We have a lot of great, brilliant minds working on this," he said. "Unfortunately we're not very close to testing because when testing starts it takes a period of time, but we'll get it done." Dr Anthony Fauci, the US government's top infectious diseases expert, had previously said that a vaccine will likely take 12-18 months to be approved for widespread use. Most health experts also agree that it